PedAM
Pediatric Disease Annotations & Medicines
| Disease | hyperparathyroidism |
| Phenotype | |chronic kidney disease |
| Sentences | 54 |
| PubMedID- 24377047 | Hifu therapy has been used in japan [50], but in other countries this therapy has been reported with contradictory results, sometimes failing [51] and sometimes showing improved results in secondary hyperparathyroidism treatment in patients with chronic kidney disease [52]. |
| PubMedID- 22210744 | Indeed, the second-generation calcimimetic, cinacalcet, has proven clinically useful in the treatment of chronic kidney disease patients with secondary hyperparathyroidism but is not widely used in earlier stages of renal disease due to the potential to predispose such patients to hypocalcaemia and hyperphosphatemia. |
| PubMedID- 21695192 | In the clinical settings, administration of 1,25(oh)2d3 is currently used as a standard of care treatment combating both 1,25(oh)2d3 deficiency and secondary hyperparathyroidism in children with chronic kidney disease-mineral and bone disorder (ckd-mbd) [9]. |
| PubMedID- 22536505 | The more effective treatment of secondary hyperparathyroidism in chronic kidney disease is probably the reason the calcium-phosphate metabolism disturbances are not the main problem in the development of sarcopenia. |
Page: 1 2